Drug Topics
MARCH 5, 2025
Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients willingness to return for future immunization.
PhRMA
MARCH 6, 2025
Lawmakers on both sides of the aisle are renewing a multi-year effort to crack down on drug middlemen, known as pharmacy benefit managers (PBMs). These middlemen control what patients pay at the pharmacy counter, where they can get their medicine, what medicines they can get and what hoops they must jump through. The effort in Congress reflects mounting pressure to hold PBMs accountable and help lower patients’ out-of-pocket costs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 7, 2025
UnitedHealth Group, the largest health care company in the U.S., has clear ambitions of getting bigger. The sprawling conglomerate — which owns a major health insurance company, physician practices, a pharmacy benefit manager, and numerous other firms — acquired or created more than 250 subsidiaries in 2024. Pretty much all of those deals weren’t publicly announced, since the transactions are small relative to UnitedHealth’s size.
The Checkup by Singlecare
MARCH 7, 2025
On March 4, 2025, the U.S. Food and Drug Administration (FDA) announced its approval of the first generic form of Xarelto (rivaroxaban), a popular anticoagulant medication. The approval is for the 2.5 mg tablets prescribed to reduce the risk of major cardiovascular events in adults with coronary artery disease (CAD) and to reduce the risk of major thrombotic vascular events in adults with peripheral artery disease (PAD).
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 4, 2025
If CMS doesnt reconsider its mandate, which forces independent pharmacies to go deep into a hole and lose money, many of them will close.
PharmaVoice
MARCH 3, 2025
Consumers want more from biopharma. Next-generation direct-to-patient programs can deliver.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MARCH 3, 2025
Panelists discuss how pharmacists employ multiple strategies to support medication adherence in older adults with TD, including simplifying dosing regimens, utilizing medication synchronization programs, providing medication packaging solutions, conducting regular follow-up calls, and collaborating closely with prescribers and care teams to develop and adjust personalized treatment plans that address individual patient needs and barriers to care.
Drug Topics
MARCH 3, 2025
In a search for new treatment and prevention strategies for pain in patients with fibromyalgia, researchers explored bioavailable nutraceuticals and phytochemicals like polyphenols.
The Checkup by Singlecare
MARCH 7, 2025
Baclofen is a muscle relaxant often prescribed to treat muscle spasms. Its often prescribed for people with muscle spasticity or tightness from multiple sclerosis , cerebral palsy, or certain types of spinal cord injuries. If you are taking baclofen, you might wonder whether its safe to drinkespecially if youre heading to an event where alcohol will be served.
STAT
MARCH 5, 2025
Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs. Wegovy normally carries a list price of about $1,350 a month, but Novo will sell the treatment through its new direct-to-consumer offering called NovoCare Pharmacy at $499 a month for all doses to ca
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
MARCH 4, 2025
Voyager Therapeutics’ progress with drug candidates targeting tau marks a step in how the industry is walking multiple paths toward new therapeutic options.
Drug Topics
MARCH 6, 2025
Researchers conducted a survey asking pharmacists their perspectives on addressing patients social determinants of health.
European Pharmaceutical Review
MARCH 7, 2025
A paper published by the Drug Safety Research Unit (DSRU) in the British Journal for Clinical Pharmacology , has asserted the need for ongoing assessment of the safety and effectiveness of the Alzheimers drug lecanemab in the real-world clinical setting. The Medicines and Healthcare products Regulatory Agency (MHRA) approved the drug for use in the UK in August 2024.
STAT
MARCH 7, 2025
After yet another record year for health data breaches, updated federal security rules to protect patient information are on the table in 2025. Patients and providers have long complained that HIPAA, or the Health Insurance Portability and Accountability Act, is ill-suited to protect patients’ sensitive health data in the digital age — and in January, the Department of Health and Human Services proposed updated regulations to protect against the growing threat of cyberattacks.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
MARCH 4, 2025
A recent study revealed the key barriers to enrollment and how pharma can help turn the tide.
Drug Topics
MARCH 4, 2025
Denosumab-Bmwo is approved for all indications of the respective reference products, including osteoporosis and high-risk of fracture due to chemotherapy.
The Checkup by Singlecare
MARCH 4, 2025
Lamotrigine (brand name Lamictal) is a prescription anticonvulsant that’s FDA approved to treat epilepsy and maintenance treatment of bipolar I disorder. It may also be prescribed off-label to treat schizophrenia , trigeminal neuralgia , and fibromyalgia. Lamotrigine works by stabilizing mood and preventing seizures, making it a vital part of treatment plans for individuals facing these conditions.
STAT
MARCH 7, 2025
In 2023, ReNAgade Therapeutics launched with $300 million to exploit an “all in one” technology solution for RNA-based therapies. That same year, Tome Biosciences emerged from stealth with $213 million to develop new gene editors, and Aera Therapeutics launched with $193 million to solve the delivery challenge for gene therapies. By the end of 2024, ReNAgade employees had faced multiple rounds of layoffs including through a corporate merger, Tome had abruptly gone from 130 employee
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmaVoice
MARCH 5, 2025
The company's vice president and general manager of U.S. business operations explains how Amgen is going to deliver on its “ambitious growth aspirations.
Drug Topics
MARCH 6, 2025
The approval is the first significant innovation for the delivery of epinephrine for this population in more than 35 years, according to the company news release.
Hospital Pharmacy Europe
MARCH 4, 2025
Medication errors frequently occur in emergency departments (EDs), placing a burden on both patients and healthcare systems. Enhanced integration of pharmacists to multidisciplinary ED teams could alleviate physician workload and improve patient care and safety, a recent study has found. This qualitative study explored physicians experiences of collaborating with pharmacists who joined emergency ED teams in two Norwegian hospitals, while also gauging their views on making such collaboration perm
STAT
MARCH 5, 2025
Jazz Pharmaceuticals said Wednesday it would spend nearly $1 billion to buy Chimerix and its experimental pill for a devastating brain tumor that primarily affects children and young adults. The tumor, known as diffuse midline glioma, or DMG (and sometimes as DIPG depending on where it’s found), has flummoxed researchers for decades. It often wraps itself around a patient’s brain stem, preventing surgeons from safely excising it.
Pharma Marketing Network
MARCH 5, 2025
Introduction In the highly regulated world of pharmaceutical marketing , mastering Google Ads management can be a game-changer. With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. However, the landscape isnt simple.
Drug Topics
MARCH 7, 2025
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed her experience when beginning to counsel patients using GLP-1 medications.
Hospital Pharmacy Europe
MARCH 4, 2025
Some hormonal contraceptives are associated with a small but significant increased risk of stroke and myocardial infarction, according to a large and detailed study from Denmark. The analysis was based on national prescription records for more than two million Danish women between 1996 and 2021. It showed that contemporary oestrogen-progestin and progestin-only contraceptives were associated with an increased risk of arterial thrombotic events.
STAT
MARCH 7, 2025
David Page’s bio reads like a history of science in the age of genomics. In 1979 he was the first student to work on what we now know as the Human Genome Project. He then became a fellow at the Whitehead Institute for Biomedical Research before joining its faculty (and MIT’s), and later served as Whitehead’s president for 16 years.
Pharmacy Times
MARCH 6, 2025
Policymakers and health care providers call for reforms to improve transparency, pricing, and patient access.
Drug Topics
MARCH 6, 2025
Cebranopadol met its primary endpoint of reduction in pain intensity as measured by the Pain Numeric Rating Scale (NRS) area under the curve from 2 through 48 hours.
Hospital Pharmacy Europe
MARCH 5, 2025
More than half of patients are unsure when their asthma inhaler is empty, with some continuing to use the device when it is empty with serious implications for managing their condition, research has shown. A study measured the amount of medicine left in more than 2,600 pressurised metered-dose inhalers that had been returned for recycling and found many were returned under or overused.
STAT
MARCH 4, 2025
After three years at the helm of controversial virtual mental health company Cerebral , David Mou has moved on and is ready to try again. He’s teamed up with Thomas Insel to form a new venture that hopes to address what the founders see as skewed incentives that sent many mental health companies down the wrong path. Mou and Insel are both psychiatrists and Insel, who led the National Institute of Mental Health for over a decade before a stint at Verily, has been a mentor to Mou through a
Pharmacy Times
MARCH 6, 2025
Elevidys offers significantly higher dystrophin production than existing Duchenne muscular dystrophy treatments but requires intensive monitoring for adverse events.
Drug Topics
MARCH 5, 2025
Researchers analyzed the association between adherence to a Mediterranean diet and obesity cancers, with a focus on the mediating role adiposity plays throughout the process.
PhRMA
MARCH 4, 2025
A tranche of recent reports reveal that the 340B hospital markup program is costing states and the federal government hundreds of millions of dollars in lost tax revenue.
Expert insights. Personalized for you.
346 
Let's personalize your content